Skip to main content
Teaser
Kapseln
Teaser
Teaser

Publications

Reviews and articles with chitosan in 2024

Reviews and articles with chitosan in 2024


After already high numbers in 2023, 4025 articles dealing with chitosan were published in 2024. That is 616 more than in the previous year. This development shows that chitosan, as a versatile biopolymer, is attracting more and more attention from researchers worldwide. Of the 4025 search results on PubMed, 247 were reviews. Thematically, the reviews dealt with the diverse application possibilities of chitosan.


Most of the reviews were published in the International Journal of Biological Macromolecules (86), Carbohydrate Polymers (30) and Polymers (Basel) (9). The main topics were the use of chitosan as nanoparticles (25 reviews) and drug delivery systems (24 articles), and in particular their use as possible cancer therapeutics (20 articles). Other reviews dealt with chitosan hydrogels (19 reviews) and the application of chitosan in tissue engineering (also 19 articles). Three reviews on different application areas are presented below:


Guo W, Ding X, Zhang H, Liu Z, Han Y, Wei Q, Okoro OV, Shavandi A, Nie L. Recent Advances of Chitosan-Based Hydrogels for Skin-Wound Dressings. Gels. 2024 Feb 29;10(3):175. doi: 10.3390/gels10030175.


Guo et al. present the use of chitosan hydrogels for wound treatment and in tissue engineering. The advances in hydrogel technology are presented. The focus is on the antibacterial, antioxidant and hemostatic properties. These make them suitable for the treatment of a variety of wounds, including inflamed and diabetic wounds. Furthermore, chemical modifications of chitosan are discussed that should further increase the therapeutic benefits of chitosan hydrogels. The outlook outlines future applications of “smart hydrogels” that will be used for targeted therapy and monitoring of wounds.

Atmaca H, Oguz F, Ilhan S. Chitosan in cancer therapy: a dual role as a therapeutic agent and drug delivery system. Z Naturforsch C J Biosci. 2024 Mar 14;79(5-6):95-105. doi: 10.1515/znc-2023-0148.


This review presents the use of chitosan as both an active ingredient and a drug delivery system in cancer therapy. Various chitosan-based nanoparticles, their modification, and their influence on the effectiveness and cytotoxicity of classic cytostatic drugs such as Palitaxel and Doxorubicin are discussed. In addition, the effect-enhancing and pro-apoptotic effects of chitosan are also highlighted, which makes it a potential candidate in combination therapy.

 

Mascarenhas R, Hegde S, Manaktala N. Chitosan nanoparticle applications in dentistry: a sustainable biopolymer. Front Chem. 2024 Apr 10;12:1362482. doi: 10.3389/fchem.2024.1362482.


In their review article, Mascarenhas et al. present the synthesis and the diverse applications of chitosan nanoparticles in dentistry. Due to its low cytotoxicity, high biocompatibility and pronounced antimicrobial effect, chitosan is suitable for numerous dental applications. Particularly promising are its possible uses in the remineralization of tooth enamel, in oral drug delivery systems, in dental hygiene, in the regeneration of dental nerves, and as a coating for dental implants to improve their durability and compatibility. These properties make chitosan a promising material for future developments in dental medicine.

 

chitosan auswertungreviews 10 april 2025 bild

Reviews and publications with chitosan in 2023

Numerous publications on the topic of chitosan were published again last year. It was observed that the number increased again compared to the previous year. While a total of 3097 publications with chitosan in the title were published in 2022, there were over 300 more publications in 2023 with 3409. We at HMC are very excited about this!

Publications and reviews with chitosan in 2022

According to HMC research (PubMed, Jan. 20, 2023), a total of 3097 publications with chitosan in the title were published in 2022. Of these, 151 were reviews with a wide variety of applications of chitosan. In this article, we would like to give you an overview of the publications and briefly introduce five of the reviews. Enjoy reading!

Chitosan Reviews in 2021

A large number of reviews on Chitosan were also published in 2021. According to HMC searches in the PubMed database, a total of 181 new reviews with chitosan in the title appeared in 2021. In this article, we would like to give you an overview of the publications, as well as briefly introduce five reviews on various topics related to chitosan. Have fun reading!

Chitosan Research in 2018

Also in 2018, scientists around the world have been feverishly researching chitosan in a variety of applications. Often involved is chitosan of highest quality, produced by Heppe Medical Chitosan. At the end of the year, we would like to present articles in which HMC Chitosan has been researched for removal of drugs in water and antibacterial action.

Publications with chitosan and chitosan derivatives by HMC in 2018

Worldwide, our chitosan and chitosan derivatives are used in research. We created a list of scientific articles published in 2018 using chitosan from HMC. Nanoparticles from chitosan or chitosan derivatives were most frequently produced and tested for a wide variety of applications, mainly directed drug delivery and tissue engineering. Curious where to find chitosan by HMC in research?

Publications in 2014

HMC.300bub007We provide you summaries of interesting scientific chitin and chitosan articles published in year 2014.

Enjoy reading!

Publications in 2015

We provide you summaries of interesting scientific chitin and chitosan articles published in year 2015

Enjoy reading!

Publications in 2012

Find an overview of scientific publications dealing with chitin and chitosan in 2012.

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.